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ABSTRACT 
Objective: The purpose of the present study was a characterization of chitosan (CS)-polypyrrole (PPY) nanocomposites for controlled release of 
anticancer drug doxorubicin (DOX). 
Methods: Chitosan crosslink with PPY with montmorillonite (MMT) called as (CS-PPY/MMT) were formulated using the solvent casting method. 
The prepared nanocomposites were characterized by X-Ray Diffraction Analysis (XRD), tensile strength, scanning electronic microscope (SEM).  
Results: The XRD result confirmed that the CS-PPY/MMT possessed crystal structure. The nanocomposites CS-PPY/MMT-4 were showed a 
homogenous morphology. The Water uptake and swelling ratio of the CS-PPY and CS-PPY/MMT were found to decrease with increase in the 
concentration of clay. Mechanical properties of the CS-PPY and CS-PPY/MMT were assessed in terms of tensile strength and extensibility using 
texture analyzer. Increase in tensile strength and reduction in extensibility was reported with an increase in the nanoclay content. In vitro drug 
release study on CS-PPY and CS-PPY/MMT indicated pronounced sustained release of doxorubicin by the incorporation of clay particles in CS-
PPY/MMT. It was observed that during the first 60 min of the dissolution study, the CS-PPY/MMT-4 film showed just 79.32±0.56% drug release as 
while the CS-PPY-1, CS-PPY/MMT-2 and CS-PPY/MMT-3 films showed a release of 53.79±1.23%, 63.51±1.24% and 68.15±2.38% respectively. 
Conclusion: CS-PPY/MMT nanocomposite films exhibited improved mechanical and sustained drug release properties than CS-PPY. The 
combination of biodegradable polymeric chains and clay reinforcement can be applied to achieve the desired combination of properties of materials 
used as a biosensor for diverse biomedical applications. 
, KAMPAL MISHRA 
Department of Physics, SOA University, Odisha, India 
Email: dilip@nsarf.in  
Keywords: Chitosan, Polypyrrole, Montmorillonite nanocomposites, Doxorubicin, Drug delivery 




Today polymeric nanomaterials have created an excellent, 
outstanding field in the pharmaceutical and medical field due to its 
extra amazing physical, chemical and biological properties [1, 2]. 
Chitosan is a most popular carbohydrate polysaccharide polymer 
which is easily available in Indian market. In recent year, Chitosan is 
known as biomaterials for drug delivery due to nontoxic, 
biocompatibility, hydrophilic nature, low molecular weight, cost-
effective, environmentally friendly properties, etc. respectively. 
Nowadays the enhancement of chitosan properties in micro and 
nano form is a new ambition for future research. Also, interesting 
properties of chitosan and its derivatives with mucoadhesion nature 
is going to the good potentiality of drug delivery system [3-5].  
Conducting polymers have been extensively studied in recent years 
because of their special properties and promising potential 
applications such as electromagnetic interference shielding, 
biosensors, actuators, field emission, and so forth. Polypyrrole is 
unique among the family of conducting polymers due to its good 
environmental stability, easy synthesis, reversible doping and redox 
properties [6]. However, the macroscopic appearance of the as-
prepared PPy is generally either an insoluble granular solid or an 
intractable brittle thin film. 
It is known that the properties of the polymer/clay composite are 
strongly affected by the addition of surfactant(s) into the composite. 
On those systems, the typical molecules are long chain alkyl 
quaternary ammonium chlorides, which are easily incorporated into 
the clay structure. Large molecule additions, except the use of long-
chain alkyl quaternary amines or polyglycol to manipulate the 
composite properties, are seldom studied [7]. 
Present study was designed to characterize the CS-PPY with MMT 
and CS-PPY polymer composites for controlled release of anticancer 
drug doxorubicin. The CS-PPY and CS-PPY/MMT films were 
evaluated in terms of SEM, FTIR, XRD, Mechanical, physical, TGA, 
swelling and in vitro release study of an anticancer drug Doxorubcin.  
MATERIALS AND METHODS 
Chemicals 
Chitosan (molecular weight ~250 kDa and ~93.0% DDA) and 
polypyrrole (PPY) were purchased from Himedia Pvt Ltd. 
Montmorilonite was purchased from Southern Clay, USA. All other 
reagents and chemicals were used as the analytical grade. Millipore 
water was used in the entire experimental work.  
Drug  
Doxorubicin hydrochloride (543.52 g/mol) C27H29NO11
Drug content pre-weighed a sample of film was placed in 100 ml of 
phosphate buffer (pH 7.4) and agitated on a mechanical shaker for 6 
h. Solution was filtered and analyzed spectrophotometrically at 224 
nm.
 was 
obtained as gifts (Newredmars Education, Pvt. Ltd India).  
Preparation of CS-PPY/MMT blends and their nanocomposites 
The CS-PPY/MMT films were prepared using CS, MMT and PPY. CS 
solution was prepared by dissolving CS in a 2% (v/v) aqueous acetic 
acid solution, followed by centrifuging to remove the insoluble 
material. MMT has first swelled in 2% (v/v) aqueous acetic acid 
solution and then added to CS solution with continuous stirring (300 
rpm) at 60 °C for 4 h. PPY was added as a conducting polymer agent. 
CS-PPY/MMT films were prepared using different ratios of CS, PPY and 
MMT as shown in table no.1. These were coded as CS-PPY-1, CS-
PPY/MMT-2, CS-PPY/MMT-3, CS-PPY/MMT-4 representing different 
wt % of MMT content (1%, 3%, 5%) respectively [8, 9]. The 
formulation codes for different films are shown in table no. 1and fig. 1. 
Drug loading  
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Table 1: Sample preparation of CS-PPY-MMT nanocomposites (n=3) 
Sample CS (in gms) PPY (%) MMT (wt %) 
CS-PPY-1 2.5 1 - 
CS-PPY/MMT-2 2.5 1 1 
CS-PPY/MMT-3 2.5 1 3 













CS molecular weight in kDa. n=3 and data are given in mean±SD, Where CS: Chitosan, PPY: polypyrrole, MMT: Montmorilonite  
Where LC: Loading content;  
LE: Loading efficiency,  
Wa:  
W
quantity of drug found in the drug-loaded nanocomposite,  
d: 
W
quantity of drug beginning added into the system  
np:  
 
Fig. 1: Schematic representation of DOX-loaded CS-PPY/MMT nanocomposite 




Scanning electron microscopy (SEM) 
Liquid nitrogen was used for freezing the CS-PPY, and CS-PPY/MMT 
sheets and then snapped quickly, and then the fractured surface was 
sputtered with gold and investigated with a Scanning electron 
microscope instrument (JSM-5900LV) using an acceleration voltage 
of 20 kV. 
X-ray diffraction (XRD) 
D8 Advance Diffractometer (Bruker, U. S. A.) equipped with a CuKα 
radiation source (λ = 0.154 nm) was utilized for X-ray diffraction. 
The diffraction data were obtained from 2θ = 1 °−80 °. 
Mechanical properties  
The tensile properties of the sample were incorporated on a 
universal testing machine (CMT4104, Shenzhen SANS Test Machine 
Co. Ltd, Central Institute of Plastics Engineering and Technology 
(CIPET), and Odisha) with a tensile rate of 5 mm/min. 
Swelling studies 
The swelling study is calculating the extent of water uptake or 
degree of dehydration. It is using at the time of fabrication of 
polymer film. It has been shown that most of the mucoadhesive 
polymers undergo some degree of swelling after hydration, which is 
necessary to initiate intimate contact of the nanocomposites with 
the mucosal surface. These studies for monitoring of swelling index 
of the nanocomposites were regulated in the phosphate buffer of pH 
7.4. The CS-PPY/MMT nanocomposites (surface area: 1.75 cm2) was 
weighed and put in a pre-weighed stainless steel wire sieve of 
approximately 900 µm mesh. The mesh containing the required 
quantity of nanocomposites was then submerged in 15 ml of the 
phosphate buffer medium contained in a porcelain dish [10]. At 
appropriated time intervals, the stainless steel mesh was removed 
from the dish, and the excess moisture was removed by carefully 
clean it off with absorbent tissue, then it was reweighed. The 
enhancement of the weight of the polymer matrix was calculated at 
each time interval until a constant weight was calculated. The degree 






Where S. I: Swelling Index,  
wt:  weight of film at time‘t’  
w0
RESULTS AND DISCUSSION 
: weight of the film at time 0  
Sem 
Fig. 2 shows SEM of CS-PPY-1 and CS-PPY/MMT-4 at 5000X 
magnifications. The nanocomposites CS-PPY/MMT-4 were showed a 
homogenous morphology in comparison with the blending polymer 
CS-PPY without clay. The CS-PPY/MMT-4 was identified the best 
nanocomposite polymer. The microstructure obtained smooth 
homogenous for CS-PPY/MMT-4 comparing with pure CS and CS-
PPY. Additionally, the surface morphology of CS-PPY/MMT-4 was 
demonstrated more exfoliated with homogenous form comparing 
with other percentages of MMT. This might boost the surface 
modification of blending polymer nanocomposites [11]. 
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Fig. 2: SEM of CS-PPY (a) and CS-PPY/MMT-4 (b) 
 
XRD 
Fig. 3a the X-ray diffraction pattern of the MMT with intense peak 
appearing near 2θ = 4.85°. In fig. 3b the diffraction peaks of CS are 
located around 10.5°, 19.2°. They are very weak, indicating low 
crystallinity. Additionally, the diffraction peaks of DOX are located at 
2θ =9.12°, 10.34°, 21.13°, 28.13°, 31.10°, 37.23°, 47.12° and 56.10°. 
This was the high crystalline structure with the strong peak for DOX. 
However, in the CS-PPY-1 polymer shows two diffraction peaks at 2θ 
=12.41°, 17.11°, 21.13°, 20.08° and 37.45°. Additionally, when MMT 
was added with CS-PPY polymer, the diffraction peaks of CS-
PPY/MMT-4 is located around 2θ =4.71°, 9.29°, 16.26°, 21.71°, 
36.14° and 46.25° [11,12]. There is negligible difference between in 
comparison with CS-PPY/MMT-2, CS-PPY/MMT-3. In other hand 
DOX was added with CS-PPY/MMT-4, three new peaks were 
observed at 5.61°, 9.49°, 17.36°, 23.41°, 35.14°, 45.35° and 50.11° 
indicating crystalline nature.  
 
 
Fig. 3: (a) XRD of MMT
 
 
Fig. 3: (b) XRD of CS, and DOX, CS-PPY, CS-PPY/MMT-2, CS-PPY/MMT-3, CS-PPY/MMT-4 
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The mechanical strength of a CS-PPY/MMT film was described in 
terms its tensile strength and percentage of elongation to break that is, 
extensibility in table no. 2. A significant influence of the MMT 
concentration on the mechanical properties of the films was observed. 
Tensile strength was observed to increase with an increase in the 
MMT content in the films. It was reported in fig. 4 that the tensile 
strength ranged from 21.13±1.26 N/mm2 in pure CS film) to 
43.21±1.23 N/mm2
Sample 
 (CS-PPY/MMT-4 film). The enhancement in tensile 
strength of the nanocomposites might be attributed to the high-aspect 
ratio and rigidity which results from the strong affinity between the 
biopolymer and nanoclay. As reported evident from literature, tensile 
strength values of CS-PPY/MMT nanocomposites increased 
significantly with increasing nanoclay concentration due to a possible 
strain-induced alignment of the nanoclay particle layers in the 
nanocomposites [12]. 
 
Table 2: Tensile strength and extensibility of CS-PPY/MMT films (n=3) 
Tensile strength (MPa) Extensibility % 
CS 21.13±1.26 19.20±1.66 
CS-PPY-1 25.12±1.23 20.42±1.56 
CS-PPY/MMT-2 34.21±2.15 11.02±1.30 
CS-PPY/MMT-3 27.06±1.02 12.13±0.26 
CS-PPY/MMT-4 43.21±1.23 10.21±2.13 
*
 
The extensibility in fig. 5 ranged from 10.21±2.13 (CS-PPY/MMT-4 
film) to 12.13±0.26 % (CS-PPY/MMT-3 film), whereas the pure CS 
film recorded extensibility of 19.20±1.66%. The effect of MMT on the 
extensibility shows a significant decrease in elongation to break as 
the MMT concentration increases. The results were found to be in 
good agreement with the findings reported by Svoboda et al., 
Hasegawa et al. and Bangyekan et al. [13, 14]. 
 
CS molecular weight in kDa. n=3 and data are given in mean±SD, Where CS: Chitosan, PPY: polypyrrole, MMT: Montmorilonite, MPa: Megapascal 
Pressure Unit 
 
Fig. 4: Tensile strength of CS, CS-PPY, CS-PPY/MMT-2, CS-
PPY/MMT-3, CS-PPY/MMT-4 n=3, and data are given in 
mean±SD 
 




The prepared CS-PPY/MMT were compact, smooth and without 
pores or imperfections. A synergistic effect of MMT for improving 
thermal stability, mechanical, and barrier properties of CS has been 
proposed. The evaluation of CS-PPY/MMT composite films in terms 
of various physicochemical properties, characterization FTIR and 
DSC studies and stability testing is discussed hereunder [15]. 
 
Table 3: Physical properties of CS-PPY/MMT composite (n=3) 










CS-PPY-1 0.14±0.12 86.81±0.11 0.27±0.14 2.76±0.11 6.77±0.12 250±1.15 7.4 
CS-PPY/MMT-2 0.12±0.13 89.22±0.23 0.31±0.27 3.61±0.26 7.69±0.21 256±1.12 7.4 
CS-PPY/MMT-3 0.22±0.31 93.43±0.14 0.41±0.12 2.31±0.13 11.31±0.15 259±1.14 7.4 
CS-PPY/MMT-4 0.33±0.42 94.61±0.22 0.49±0.21 2.39±0.27 9.46±0.23 269±1.23 7.4 
*
 
CS molecular weight in kDa. n=3 and data are given in mean±SD, Where CS: Chitosan, PPY: polypyrrole, MMT: Montmorilonite  
Table 3 depicts various physicochemical properties of the prepared 
CS-PPY/MMT films. The polymeric combination of CS-PPY with MMT 
exhibited good film-forming properties and the method of casting of 
films was found to produce good films. The thickness of the films 
vary from 0.12±0.13 to 0.33±0.42 mm while the drug content in the 
films ranges from 86.81±0.11% to 94.61±0.22%. The weight of the 
films ranged from 0.27±0.14 to 0.49±0.21 g. The results indicated 
that the method selected for the preparation of films was capable of 
producing films with uniform weight, content and minimal film 
variability. The folding endurance was found to be ranging between 
250±1.15 and 269±1.23 indicating that the formulated films would 
maintain their integrity when applied to the skin. The pH of the films 
near about 7.4. Low moisture content is useful for the long term 
stability of the films. It also reduces the brittleness and protects the 
formulation from microbial contamination. Moisture content and 
moisture uptake studies indicated that the increase in the 
concentration of hydrophilic polymer was directly proportional to 
the increase in moisture content and moisture uptake of the films, 
whereas increase in the concentration of hydrophobic polymer lead 
to the decrease in moisture content and moisture uptake of the films. 
Behera et al. 




The swelling ratio studies performed on the films are shown in fig. 6. 
Similar to the water uptake studies in fig. 7, the swelling studies also 
showed a decrease in the swelling of the films with a decrease in the 
CS concentration. The swelling ratio was reported to be in the order 
CS-PPY/MMT 4>CS-PPY/MMT-2>CS-PPY/MMT-3>CS-PPY/MMT-1. 
The behavior could be explained in terms that the MMT clay 
particles occupy the free space volume in the CS polymeric network 
thereby decreasing the volume available for swelling [16]. 
  
 
Fig. 6: Swelling ratio of CS, CS-PPY, CS-PPY/MMT-2, CS-PPY/MMT-3, CS-PPY/MMT-4 n=3 and data are given in mean±SD 
 
 
Fig. 7: Water uptake CS, CS-PPY, CS-PPY/MMT-2, CS-PPY/MMT-3, CS-PPY/MMT-4 n=3 and data are given in mean±SD 
 
In vitro release study 
The results obtained from the in vitro dissolution study of the films 
are presented in fig. 8. The order of increased drug dissolution using 
the different approaches was as follows; CS-PPY/MMT-1>CS-
PPY/MMT-2>CS-PPY/MMT-3>CS-PPY-4. It was observed that during 
the first 60 min of the dissolution study, the CS-PPY/MMT-4 film 
showed just 79.32±0.56% drug release as while the CS-PPY-1, CS-
PPY/MMT-2, and CS-PPY/MMT-3 films showed a release of 
53.79±1.23%, 63.51±1.24%, and 68.15±2.38% respectively. Results 
of various film tests indicate that among the three samples used for 
the preparation of CS-PPY/MMT films, CS-PPY/MMT-4 and CS-
PPY/MMT-2 were more effective method than CS-PPY-1 and CS-
PPY/MMT-3. This is quite evident from the drug release behavior of 
the CS-PPY/MMT films after 8 h of dissolution study respectively.  
CS-PPY/MMT-4 and CS-PPY/MMT-2 showed better-sustained 
release effects. This kind of behaviour is a result of the strong 
electrostatic interaction between the cationic charges of CS and the 
anionic charges of MMT [17, 18]. 
 
 
Fig. 8: In vitro drug release of CS-PPY/MMT films n=3 and data are given in mean±SD 
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In vitro permeation study  
Fig. 9 presents the results obtained from the in vitro permeation 
study of the films. The order of increased drug dissolution using the 
different approaches was as follows; CS-PPY/MMT-1>CS-PPY/MMT-
2>CS-PPY/MMT-3>CS-PPY-4. Similar to the in vitro drug release 
effects, these results also clearly show that the CS-PPY/MMT-4 show 
the most sustained release effects as the release of the drug after 8 h 
of permeation study was 73.59%±2.01%. This phenomenon 
confirms that anionic exchange reaction occurred between CS and 




Fig. 9: In vitro permeation study of the CS-PPY/MMT films n=3 and data are given in mean±SD 
 
Determination of release kinetics 
The regression coefficient (r2
Due to the swelling ability of the polymer, there is an opening of the 
pore channels in between the polymer matrix which helps with the 
diffusion of the drug through the polymer matrix chains, thus, 
releasing the drug from the films. Table 4 depicts the values of 
various release kinetics parameters for the films [10, 19-22]. 
 
Table 4: Release kinetic parameters of films of DOX (n=3) 
) values of Higuchi equation for CS-
PPY/MMT films CS-PPY-1, CS-PPY/MMT-2, CS-PPY/MMT-3 and CS-
PPY/MMT-4 were found to be 0.9927, 0.9946, 0.9837 and 0.9778 
respectively. To further confirm the mechanism of drug release from 
the CS/MMT films, the in vitro dissolution data were subjected to the 
Korsmeyer’s Peppas equation. The values of the release exponent 
(n) were found to be ranging between 0.43 and 0.62 indicating a 
non-fiction (anomalous) drug release behavior.  
Sample  Zero-order First order Higuchi Korsmeyer peppas Hixon crowell 
r k2 r0 k2 r0 k2 r0 n 2 k r0 k2 0 
CS-PPY-1 0.8734 0.1314 0.9831 0.0007 0.9927 2.7631 0.9921 0.4311 0.7343 0.9821 0.0016 
CS-PPY/MMT-2 0.8579 0.1347 0.9421 0.0007 0.9946 2.8842 0.9932 0.4513 0.7231 0.9676 0.0015 
CS-PPY/MMT-3 0.9142 0.1211 0.9641 0.0007 0.9837 2.9732 0.9767 0.5292 0.8143 0.9343 0.0013 
CS-PPY/MMT-4 0.9453 0.1021 0.9713 0.0008 0.9778 2.5271 0.9323 0.6271 0.8937 0.9559 0.0018 
*
 
CS molecular weight in kDa. n=3 and data are given in mean±SD, Where CS: Chitosan, PPY: polypyrrole, MMT: Montmorilonite, DOX: Doxorubicin 
CONCLUSION 
The prepared nanocomposites were formulated using the solvent 
casting method. CS-PPY/MMT polymer composite was evaluated for 
physical parametric tests, tensile strength, moisture content, swelling, 
in vitro dissolution studies. The effect of MMT for enhancing 
mechanical and barrier properties of CS-PPY matrix has been noticed. 
This could be understood as due to a formation of filler network of 
MMT within the CS-PPY polymeric chains. The values of the tensile 
strength of CS-PPY/MMT film increased significantly with increasing 
MMT concentration, while the values of extensibility decreased for 
high values of MMT concentration. Additionally, doxorubicin-loaded 
CS-PPY/MMT nanocomposite can be of immense importance in the 
drug delivery. The combination of biodegradable polymeric chains and 
clay reinforcement can be applied to achieve the desired combination 
of properties (mechanical, swelling and controlled release) of 
materials used as a biosensor for diverse biomedical applications. 
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